We have located links that may give you full text access.
Clinically significant radiographic parameter for thoracic myelopathy caused by ossification of the ligamentum flavum.
European Spine Journal 2018 September 7
PURPOSE: To investigate radiographic parameters to improve the accuracy of radiologic diagnosis for ossification of ligamentum flavum (OLF)-induced thoracic myelopathy and thereby establish a useful diagnostic method for identifying the responsible segment.
METHODS: We classified 101 patients who underwent surgical treatment for OLF-induced thoracic myelopathy as the myelopathy group and 102 patients who had incidental OLF and were hospitalized with compression fracture as the non-myelopathy group between January 2009 and December 2016. We measured the thickness of OLF (TOLF), cross-sectional area of OLF (AOLF), anteroposterior canal diameter, and the ratio of each of these parameters.
RESULTS: Most OLF cases with lateral-type axial morphology were in the non-myelopathy group and most with fused and tuberous type in the myelopathy group. Most grade-I and grade-II cases were also in the non-myelopathy group, whereas grade-IV cases were mostly observed in the myelopathy group. The AOLF ratio was found to be the best radiologic parameter. The optimal cutoff point of the AOLF ratio was 33.00%, with 87.1% sensitivity and 87.3% specificity. The AOLF ratio was significantly correlated with preoperative neurological status.
CONCLUSIONS: An AOLF ratio greater than 33% is the most accurate diagnostic indicator of OLF-induced thoracic myelopathy. In cases of multiple-segment OLF, confirmation of cord signal change on MRI and an AOLF measurement will help determine the responsible segment. AOLF measurement will also improve the accuracy of diagnosis of OLF-induced thoracic myelopathy in cases of grade III or extended-type axial morphology. These slides can be retrieved under Electronic Supplementary Material.
METHODS: We classified 101 patients who underwent surgical treatment for OLF-induced thoracic myelopathy as the myelopathy group and 102 patients who had incidental OLF and were hospitalized with compression fracture as the non-myelopathy group between January 2009 and December 2016. We measured the thickness of OLF (TOLF), cross-sectional area of OLF (AOLF), anteroposterior canal diameter, and the ratio of each of these parameters.
RESULTS: Most OLF cases with lateral-type axial morphology were in the non-myelopathy group and most with fused and tuberous type in the myelopathy group. Most grade-I and grade-II cases were also in the non-myelopathy group, whereas grade-IV cases were mostly observed in the myelopathy group. The AOLF ratio was found to be the best radiologic parameter. The optimal cutoff point of the AOLF ratio was 33.00%, with 87.1% sensitivity and 87.3% specificity. The AOLF ratio was significantly correlated with preoperative neurological status.
CONCLUSIONS: An AOLF ratio greater than 33% is the most accurate diagnostic indicator of OLF-induced thoracic myelopathy. In cases of multiple-segment OLF, confirmation of cord signal change on MRI and an AOLF measurement will help determine the responsible segment. AOLF measurement will also improve the accuracy of diagnosis of OLF-induced thoracic myelopathy in cases of grade III or extended-type axial morphology. These slides can be retrieved under Electronic Supplementary Material.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app